Patient-Reported Outcomes of Mirogabalin in Patients with Postoperative Spinal Cord-Related Central Neuropathic Pain Inadequately Controlled with Conventional Gabapentinoids: A Retrospective Real-World Study.
Switching to mirogabalin provided additional clinically meaningful pain relief in approximately half of the patients with persistent postoperative spinal cord-related central neuropathic pain that was inadequately controlled with conventional gabapentinoids.